Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Takotsubo cardiomyopathy in Guillain-Barré syndrome.
Terayama A, Kuwahara M, Yoshikawa K, Yamagishi Y, Samukawa M, Yamashita S, Onishi K, Nagano T, Tatsumi C, Ishii J, Kawamoto M, Tokashiki T, Deguchi S, Deguchi K, Ishida A, Baba Y, Yamaguchi S, Kusunoki S, Nagai Y. Terayama A, et al. Among authors: kusunoki s. J Neurol. 2024 Jul;271(7):4067-4074. doi: 10.1007/s00415-024-12295-3. Epub 2024 Apr 4. J Neurol. 2024. PMID: 38573364
[Novel Therapy in Guillain-Barré Syndrome].
Kuwahara M, Kusunoki S. Kuwahara M, et al. Among authors: kusunoki s. Brain Nerve. 2016 Dec;68(12):1423-1429. doi: 10.11477/mf.1416200612. Brain Nerve. 2016. PMID: 27916752 Japanese.
Guillain-Barré syndrome and related diseases after influenza virus infection.
Yamana M, Kuwahara M, Fukumoto Y, Yoshikawa K, Takada K, Kusunoki S. Yamana M, et al. Among authors: kusunoki s. Neurol Neuroimmunol Neuroinflamm. 2019 May 21;6(4):e575. doi: 10.1212/NXI.0000000000000575. eCollection 2019 Jul. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31355311 Free PMC article.
[The prognosis and prognostic factor of Guillain-Barré Syndrome].
Yamagishi Y, Kusunoki S. Yamagishi Y, et al. Among authors: kusunoki s. Rinsho Shinkeigaku. 2020 Apr 24;60(4):247-252. doi: 10.5692/clinicalneurol.cn-001398. Epub 2020 Mar 31. Rinsho Shinkeigaku. 2020. PMID: 32238748 Review. Japanese.
Clinical features of CIDP with LM1-associated antibodies.
Kuwahara M, Suzuki H, Samukawa M, Hamada Y, Takada K, Kusunoki S. Kuwahara M, et al. Among authors: kusunoki s. J Neurol Neurosurg Psychiatry. 2013 May;84(5):573-5. doi: 10.1136/jnnp-2012-303440. Epub 2012 Nov 8. J Neurol Neurosurg Psychiatry. 2013. PMID: 23138763
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: kusunoki s. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
507 results